“You guys (shares holders) are just doing what the short sellers wanted!”
No, shareholders are asking for an unqualified and underperforming CEO to step down or be removed by the BOD. He got CYDY to this point but cannot push leronlimab past the finish line. He can take his shares and be wealthy in the future when the new CEO get leronlimab to the market.
News 
Market Data 
Discover 
AI
